[The efficacy of hyperbaric oxygen in the treatment of sudden sensorineural hearing loss]. | Canada Hyperbarics Skip to main content
Clinical Study Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery 2020

[The efficacy of hyperbaric oxygen in the treatment of sudden sensorineural hearing loss].

Hu Y, Chen H, Xiong J, Sun W — Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery, 2020

View Original on PubMed PMID 32842183
Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

The researchers investigated the therapeutic effect of hyperbaric oxygen on sudden sensorineural hearing loss (SSNHL) by randomly assigning 107 patients to receive either hyperbaric oxygen once daily, twice daily, or no hyperbaric oxygen, all in addition to conventional treatment.

What They Found

The overall effective rate was 78.9% in patients receiving hyperbaric oxygen once daily and 81.5% in those receiving it twice daily, compared to 61.9% in the conventional treatment group. Hearing threshold improvements were 27.2 dB HL and 26.9 dB HL for the hyperbaric oxygen groups, respectively, versus 17.6 dB HL for the conventional treatment group.

What This Means for Canadian Patients

Canadian patients with sudden sensorineural hearing loss might benefit from hyperbaric oxygen therapy as an adjunct to conventional treatments. This could potentially lead to better hearing recovery outcomes for those affected by this condition.

Canadian Relevance

This study has no direct Canadian connection as it was conducted outside of Canada.

Study Limitations

A limitation is that the full statistical analysis and detailed patient characteristics were not provided in the abstract.

Was this summary helpful?

Study Details

Study Type Clinical Study
Category Sudden Hearing Loss
Source Pubmed
PubMed ID 32842183
Year Published 2020
Journal Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery
MeSH Terms Audiometry, Pure-Tone; Glucocorticoids; Hearing Loss, Sensorineural; Hearing Loss, Sudden; Humans; Hyperbaric Oxygenation; Treatment Outcome

Cite This Study

Share

Related Research

J Craniofac Surg | 2026 Study

Emergency Department Sudden Deafness: Clinical Features and Predictors of Advanced Imaging

Erinmez M, Örs F, Yeşilova M
Avicenna J Med | 2026 Case Report

Hyperbaric Oxygen Therapy for Sensorineural Hearing Loss from

Abdalkarim M, Harris M, Drees S, Alhroob T, Bansal N
Diving and hyperbaric medicine | 2026 Retrospective Study

Treatment success in relation to timing of hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss.

Lun CY, Au Yeung KL, Lau YF, Yan WW, Tang KB
Hearing research | 2026 Retrospective Study

''Comparing the effectiveness of the combination of hyperbaric oxygen therapy and systemic glucocorticoids in the treatment of sensorineural hearing loss resulting from shooting noise versus blast injury''.

Gur I, Gur I, Mogilevski L, Jerdev T, Nov Y
Medical journal, Armed Forces India | 2026 Prospective Study

Role of hyperbaric oxygen therapy in idiopathic sudden sensorineural hearing loss management: A multicentre experience.

Gupta DK, Rai N, Sood A, Kumar S, Das B, Nagarjuna P, et al.
See all Sudden Hearing Loss research
View on PubMed Back to Research Library

Find a Canadian Clinic Treating Sudden Hearing Loss

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.